LabLife
ActiveSummary
The computed 12-month bankruptcy probability of LabLife is 2.7% (moderate). The 2025 annual accounts show negative equity (-€91,647) and a net result of -€203,474. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 13% of 1,663 sector peers (NACE 62, financial year 2025). The company has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals.
Group and network
Part of the group
Nuclys
450 companies
Group, risk and exposure
Connections & network
The network starts from this company’s shareholders. What else they own or run appears here as nodes.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.